common.study.topics.clinical

Cardiovascular Complications of Sickle Cell Disease

common.study.values.description

Cardiovascular Complications of Sickle Cell Disease

In this research study, we are using heart imaging exams and blood testing, in order to gain an improved understanding of the pulmonary (lung) hypertension and cardiovascular (heart) complications that often occur in sickle cell patients. Information gathered from the healthy volunteers that participate in this study will be compared to information from the sickle cell patients in this study in order to help further our understanding.

common.study.values.location

participant.ui.study.affiliations-map.online-study.header-virtual

participant.ui.study.affiliations-map.online-study.text

participant.ui.study.affiliations-map.legend.locations participant.ui.study.affiliations-map.legend.selected

common.study.values.methods

No pharmaceutical medication involved common.study.methods.has-drugs-no
Patients and healthy individuals accepted common.study.methods.is-healthy-no

Procedure - MRI, Transthoracic Echocardiography, tonometry, EKG

Unless contraindicated, subjects will receive Regadenoson and Gadolinium contrast agent during the Cardiac magnetic resonance. The tonometer, EKG, and echo are non-invasive procedures.

participant.views.study.view.additional

participant.views.study.view.scientific-title

Cardiovascular Complications of Sickle Cell Disease

common.study.values.clinical-trial-id

NCT01044901

participant.views.study.view.id

1aMj3b